Whalesbook
Strategic Pivot to Value
The Indian pharmaceutical industry is actively transitioning from a volume-centric model to one emphasizing value and innovation. This strategic recalibration involves a heightened focus on developing complex generics and biosimilars, alongside fostering groundbreaking research and development. The objective is clear: to ascend the global value chain and capture higher market share through specialized products.
Robust Export Performance
India's pharmaceutical sector already holds a commanding position globally, ranking third by volume. It fulfills about 20% of the world's demand for generic medicines. In the fiscal year 2025, the sector achieved an annual turnover of ₹4.72 lakh crore. Exports have shown consistent growth, expanding at a compound annual growth rate (CAGR) of 7% over the past decade. More than half of these exports are directed towards highly regulated markets like the United States and Europe, underscoring the industry's adherence to stringent quality standards.
Medical Devices Sector Growth
Beyond pharmaceuticals, the medical devices sector is also demonstrating significant momentum. Exports in this segment surged from USD 2.5 billion in FY21 to USD 4.1 billion in FY25. To accelerate this growth and reduce import dependency, the adoption of advanced manufacturing technologies, including Artificial Intelligence and 3D printing, is critical. Streamlining global certification processes is also key to enhancing international market access and competitiveness.
Global Leadership in Vaccines
India continues its leadership role in the supply of low-cost vaccines globally. It provides a substantial majority of the world's diphtheria, tetanus, pertussis (DPT), Bacillus Calmette-Guerin (BCG), and measles vaccines. This consistent supply chain strength reinforces India's position as a crucial player in global public health initiatives.
High-Tech Manufacturing Ambitions
The medical devices industry is moving beyond basic supplies to manufacture high-end equipment. This includes sophisticated items such as MRI and CT scanners, linear accelerators, cardiac stents, and ventilators. This expansion into advanced imaging and life-support technologies signifies a significant leap towards high-tech medical manufacturing, positioning India as a more comprehensive healthcare solutions provider.